IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Qiming U.S. Ventures Management, LLC

Q2 2022 Holdings

Filed 2022-07-22 | 7 holdings | $72.0K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Icosavax IncCOM45114M109$20.1K3,510,22827.9%
Talaris Therapeutics IncCOM87410C104$13.2K2,932,60618.4%
Jasper Therapeutics IncCOM471871103$11.3K5,852,98215.7%
Ventyx Biosciences Inc(VTYX)COM92332V107$11.1K910,30615.5%
Kezar Life Sciences IncCOM49372L100$6.9K828,7119.5%
Hillevax IncCOM43157M102$6.1K558,9238.5%
Elevation Oncology IncCOM28623U101$3.3K2,370,1424.6%